Synthesis and Biological Evaluation of 4‑Substituted Fluoronucleoside Analogs for the Treatment of Hepatitis B Virus Infection
datasetposted on 2015-05-14, 00:00 authored by Qinghua Yang, Jinfeng Kang, Liyun Zheng, Xue-Jun Wang, Na Wan, Jie Wu, Yan Qiao, Pengfei Niu, Sheng-Qi Wang, Youmei Peng, Qingduan Wang, Wenquan Yu, Junbiao Chang
A series of 4-substituted fluoronucleosides have been synthesized in order to address the toxicity issue of the parent compound 7, and after in vitro evaluation, the cyclopropylamino analog 1f was selected for in vivo study. In mice, this compound exhibited a significantly improved toxicity profile. Administered orally, compound 1f was well-tolerated at a dose up to 3 g/kg and showed insignificant toxicity on white blood cells and a low mutagenic effect at dosages up to 80 mg/kg (single) or 20 mg/kg/day (5 days). In duck HBV (DHBV)-infected duck models, both the serum and liver DHBV DNA levels (74.2 and 82.1%, respectively) were markedly reduced by the treatment of 1f at a dose of 1 mg/kg/day for 10 days. In addition, both the viral DNA levels had a lower degree of recovery after withdrawal of the test compound for 3 days.